Building Competency in Diabetes Education THE ESSENTIALS

TREATMENT MODALITIES: PHARMACOLOGICAL THERAPIES | 6-45

SAFETY CONSIDERATIONS WITH ANTIHYPERGLYCEMIC AGENTS

1. Renal function Renal function should be evaluated prior to initiating pharmacological therapies, as well as ongoing, to assess the need to alter the dose or agent with a decline in renal function (see to Figure 2).

Figure 2